REFERENCES
- Spector S.L., Katz F.H., Farr R.S. Troleandomycin: Effectiveness in Steroid-Dependent Asthma and Bronchitis. J. Allergy Clin. Immunol. 1974; 54: 367–379
- Kamada A.K., Hill M.R., Ikle D.N., Brenner M., Szefler S.J. Efficacy and Safety of Low-Dose Troleandomycin Therapy in Children with Severe, Steroid-Requiring Asthma. J. Allergy Clin. Immunol. 1993; 91: 873–882
- Kudoh S. Erythromycin Treatment in Diffuse Panbronchiolitis. Curr. Opin. Pulm. Med. 1998; 4: 116–121
- Scaglione F., Rossoni G. Comparative Anti-Inflammatory Effects of Roxithromycin, Azithromycin and Clarithromycin. J. Antimicrob. Chemother 1998; 41(Suppl B)47–50
- Anderson R., Theron A.J., Feldman C. Membrane-Stabilizing, Anti-Inflammatory Interactions of Macro-lides with Human Neutrophils. Inflammation 1996; 20: 693–705
- Cockroft D.W., Killian D.N., Mellon J.A., Hargreave F.E. Bronchial Reactivity to Inhaled Histamine: A Method and Clinical Survey. Clin. Allergy 1977; 7: 235–243
- Kobayashi H., Takeda H., Sakayori S., Kawakami Y., Otsuka Y., Tamura M., Konishi K., Tanimoto S., Fukakusa M., Shimada K. Study on Azithromycin in Treatment of Diffuse Panbronchiolitis. Kansenshoogaku Zasshi. 1995; 69: 711–722
- Labro M.T. Anti-inflammatory Activity of Macro-lides. J. Antimicrob. Chemother. 1998; 41(Suppl B)37–46
- Konno S., Asano K., Kurokawa M., Ikeda K., Okamoto K., Adachi M. Antiasthmatic Activity of Macrolide Antibiotic, Roxitromycin: Analysis of Possible Mechanism in vitro and in vivo. Int. Arch. Allergy Immunol. 1994; 105: 308–316
- Okubo Y. Macrolides Reduce the Expression of Surface Mac-1 Molecule on Neuthrophil. Kurume Med. J. 1997; 44: 115–123
- Takizawa H., Desaki M., Ohtoshi T., Okazaki H., Sato Makiyama N., Shoji S., Hiramatsu K., Ito K. Erythromycin Suppresses IL-6 Expression by Human Bronchial Epithelial Cells. Biochem. Biophys. Res. Commun. 1995; 25(210)781–786
- Adachi T., Motojima S., Hirata A., Fukuda T., Kihara N., Kosaku A., Ohtake H., Makino S. Eosinophil Apoptosis Caused by Theophilline, Glucocorticoids and Macrolides After Stimulation with IL-5. J. Allergy Clin. Immunol. 1996; 98: 207–215
- Hirohata S., Nakanishi K. Suppression of Cyto-kine Production of Human Memory T Cells by Roxithromycin. Arerugi 1995; 44: 1322–1330
- Konno S., Adachi M., Asano K., Okamoto K., Takashi T. Anti-Allergic Activity of Roxithromycin: Inhibition of Interleukin-5 Production from Mouse T Lymphocytes. Life Sci. 1993; 52: 25–30
- Kino T., Hatanaka H., Miyata S., Inamura N., Nishimaya M., Yajima T. FK-506, a Novel Immunosupresant Isolated from a Streptomyces. J. Antibiotics 1987; 40: 1256–1265
- Morikawa K., Oseka F., Morikawa S., Iwamoto K. Immunomodulatory Effects of Three Macrolides, Midecamycin Acetate, Josamycin and Clarithro-mycin on Human T Lymphocyte Function in vitro. Antimicrob. Agents Chemother. 1994; 38: 2643–2647
- Feldman C., Anderson R., Theron A.J., Ramafi G., Cole P.J., Wilson R. Roxithromycin, Clarithromycin, and Azithromycin Attenuate the Injurious Effects of Bioactive Phospholipids on Human Respiratory Epithelium in vitro. Inflammation 1997; 21: 655–665
- Miyatake H., Taki F., Taniguchi H., Suzuki R., Takagi K., Satake T. Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma. Chest 1991; 99: 670–673
- Shimizu T., Kato M., Mochizuki H., Tokuyama K., Morikawa A., Kuroume T. Roxithromycin Reduces the Degree of Bronchial Hyperresponsiveness in Children with Asthma. Chest 1994; 106: 458–461
- Levert H. Azithromycin Impact on Neutrophil Oxidative Metabolism Depends on Exposure Time. Inflammation 1998; 22: 191–201